Levonic-Opto (Levofloxacin)

Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By blocking these enzymes, it stops bacterial cell division, leading to bacterial death and resolution of the infection.

The dosing regimen for Levonic-Opto is determined by the prescribing clinician based on the specific infection, severity, and patient factors. The product is supplied as an ophthalmic solution to be instilled according to the prescriber’s instructions.

Safety data for levofloxacin use in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order Levonic-Opto, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Levonics-Opto offers broad‑spectrum coverage against Gram‑positive and Gram‑negative ocular pathogens, similar to other fluoroquinolone eye drops such as moxifloxacin. Compared with older agents like chloramphenicol, levofloxacin generally provides higher potency and a lower risk of resistance, though choice depends on local susceptibility patterns and clinician preference.

Levonics-Opto should be stored at ambient temperature, below 25 °C, in its original container. Protect the solution from moisture and direct sunlight. Do not freeze the product, and keep the vial tightly sealed when not in use.

Levonics-Opto is applied as eye drops. The prescribed number of drops is placed into the conjunctival sac of the affected eye(s) using the provided dropper, typically several times a day as directed by the prescriber. Patients should avoid touching the dropper tip to the eye or any surface.

Serious risks, though rare, include corneal ulceration or perforation, severe allergic reactions such as anaphylaxis, and systemic fluoroquinolone effects like tendon rupture or QT‑interval prolongation. Patients should seek immediate medical attention if they experience severe eye pain, vision changes, or systemic symptoms.

Levonics-Opto should not be used by individuals with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation. Caution is also advised for patients with a history of tendon disorders, cardiac arrhythmias, or those taking medications that prolong the QT interval.